<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04748809</url>
  </required_header>
  <id_info>
    <org_study_id>191900</org_study_id>
    <nct_id>NCT04748809</nct_id>
  </id_info>
  <brief_title>Effect of Anti-inflammatory Diet in Rheumatoid Arthritis</brief_title>
  <official_title>An Evaluator-blinded Randomized Controlled Trial Study of the Effect of Anti-inflammatory Diet in Subjects With Rheumatoid Arthritis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In a previous exploratory study, the investigators observed an effect on disease activity&#xD;
      outcomes of anti-inflammatory diet. The investigators also observed change in microbiome and&#xD;
      circulating metabolites. The current study will determine whether or not the addition of&#xD;
      anti-inflammatory diet improves the clinical outcomes in participants with rheumatoid&#xD;
      arthritis, and the role of microbiome and circulating metabolites.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Anticipated">November 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease of more than 5 points in Clinical Disease Activity Index</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">124</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Arm_1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Anti-inflammatory diet 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm_2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Anti-Inflammatory diet 2</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diet 1</intervention_name>
    <description>Dietary intervention</description>
    <arm_group_label>Arm_1</arm_group_label>
    <other_name>anti-inflammatory diet 1</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diet 2</intervention_name>
    <description>Dietary intervention</description>
    <arm_group_label>Arm_2</arm_group_label>
    <other_name>anti-inflammatory diet 2</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with low or moderate disease activity (defined as Clinical Disease Activity&#xD;
             Index â‰¤ 22) and without changes in disease activity or therapy during the previous 3&#xD;
             months, who are interested in dietary intervention, and are able to provide consent&#xD;
             and attend to follow up visits.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy or lactating. Patients that will become pregnant during the study will be&#xD;
             remove from the study.&#xD;
&#xD;
          -  Food allergies&#xD;
&#xD;
          -  Subjects with significant other comorbidities and /or medication use which in&#xD;
             physician's clinical judgment might difficult the interpretation of the results&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Monica Guma, MD, PhD</last_name>
    <phone>8588226523</phone>
    <email>mguma@health.ucsd.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>UCSD</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roxana Coras, MD</last_name>
      <phone>858-822-6523</phone>
      <email>rcoras@health.ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Monica Guma, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>January 26, 2021</study_first_submitted>
  <study_first_submitted_qc>February 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2021</study_first_posted>
  <last_update_submitted>April 18, 2021</last_update_submitted>
  <last_update_submitted_qc>April 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Monica Guma</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Inflammatory Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

